Walgreen Co. v. Rullan

292 F. Supp. 2d 298, 2003 U.S. Dist. LEXIS 19498, 2003 WL 22472158
CourtDistrict Court, D. Puerto Rico
DecidedSeptember 8, 2003
DocketCIV. 00-1227(HL)
StatusPublished
Cited by1 cases

This text of 292 F. Supp. 2d 298 (Walgreen Co. v. Rullan) is published on Counsel Stack Legal Research, covering District Court, D. Puerto Rico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walgreen Co. v. Rullan, 292 F. Supp. 2d 298, 2003 U.S. Dist. LEXIS 19498, 2003 WL 22472158 (prd 2003).

Opinion

OPINION AND ORDER

LAFFITTE, Chief Judge.

Before the Court are both Plaintiffs’ and Defendant’s Motions for Summary Judgment (See Dkts. 115 and 122, respectively), and their Oppositions (See Dkts. 127 and 126, respectively). Plaintiffs are Walgreen Company and two wholly owned subsidiaries operating in Puerto Rico (collectively “Walgreens”). Plaintiffs bring this action pursuant to 42 U.S.C.A § 1983 1 against John V. Rullan, Puerto Rico’s Secretary of Health (the “Secretary”). 2 Walgreens challenges the regime which is applied in Puerto Rico to the opening and relocation of pharmacies. The specific provisions are sections 334 to 334j of Puerto Rico’s Title 24 and the supporting regulations (the “CNC Act”).

Under this regime, a party seeking to open or relocate a pharmacy must first obtain a Certificate of Necessity and Convenience (“CNC”) from the Secretary of Health. 24 P.R. Laws Ann. §§ 334 & 334a (1999). The law empowers the Secretary to develop criteria for the issuing of a CNC. The factors to be considered include any “long-term service development plan” of the party seeking the CNC; the current and projected needs of the population to be served by the pharmacy; the percent of the population of the area which would be served by the pharmacy; the current status of the “health system operating in the area”; and the possible existence of alternatives. Id. § 334b.

The Secretary is also responsible for establishing a procedure for evaluating *304 CNC applications. Id. § 334f-2. Under this procedure, a party must first submit a letter to the Department of Health stating that it has an interest in seeking a CNC. The party must then file its application. Once the application is submitted, the Department of Health publishes notices of the application in area newspapers and sends letters to pharmacies in the affected area of the application. The existing pharmacies then submit any objections they may have to the proposed action. After-wards, the Department of Health holds an administrative hearing, at which both the applicant and any objecting pharmacies may submit evidence and expert testimony on, among other things, whether the existing pharmacies are already adequately serving the affected area. After the administrative decision is issued, any disgruntled party may move for reconsideration and seek judicial review to Puerto Rico’s Circuit Court of Appeals and Supreme Court.

The Court held Oral Arguments on June 9, 2003 on this matter. During Oral Arguments, the parties agreed to waive the bench trial for this case and requested that the Court issue a ruling based on the parties’ respective motions for summary judgment. These motions properly brief the Court on their respective issues. The Court consented to the parties’ request, and the Court is now ready to rule.

I PROCEDURAL HISTORY

This civil action was filed on February 24, 2000. On April 17, 2000, the Secretary filed a Motion to Dismiss duly opposed by Walgreens. 3 On September 28, 2001, this Court issued an Opinion and Order 4 dismissing Walgreens’ claim that the CNC law and regulations violate, on their face, the dormant Commerce Clause. Upon dismissing this claim, the Court noted that Walgreens’ remaining claims challenged the application of the CNC Act and its regulations on substantive due process and Commerce Clause grounds. On October 18, 2001, Walgreens moved for reconsideration of the Court’s Opinion and Order and filed an Amended Complaint where it allegedly supplements the averments made in its original complaint and clarifies the basis of its facial challenge to the CNC Act. 5

Subsequent to the Court’s opinion, on February 5, 2002, the Puerto Rico Supreme Court issued its decision in Asocia-ción de Farmacias de la Comunidad v. Departamento de Salud, where it invalidated Regulation 89 and reinstated Regulation 56 as the basis for processing CNC petitions by the Secretary of Health. See Id., 2002 TSPR 13, 2002 WL 206999 (Feb. 5, 2002); Asociación de Farmacias de la Comunidad v. Departamento de Salud, 2002 TSPR 69, 2002 WL 1159514 (May 23, 2002). The Supreme Court found that Regulation 89 did not provide specific standards to guide the Secretary’s discretion and therefore, the regulation constituted an invalid delegation of legislative authority. In response, the Court revived Regulation 56 prospectively for new CNC applications. According to the Secretary, he is currently in the process of enacting a new Regulation to replace Regulation 89. 6

On March 27, 2002, the Court ordered Plaintiffs to further amend the complaint in the wake of the Puerto Rico Supreme Court’s decision in Asociación de Farma-cias de la Comunidad, and denied Plaintiffs’ October 18, 2001 motion to reconsider as moot. 7 Notwithstanding, Walgreens *305 understood its that its Amended Complaint effectively reinstated its facial Commerce Clause challenge to the CNC Act. 8 Moreover, on October. 21, 2002, the Secretary filed a motion to dismiss after Walgreens’ Amended Complaint. 9 It appears that the Court’s order mooting Plaintiffs’ motion for reconsideration has confused the parties as to the status of Walgreens’ facial challenge to the CNC Act. Walgreens asserts that if its understanding is incorrect, then it reasserts its arguments set forth in its motion for reconsideration. In light of the present confusion, and given that both parties have properly briefed the Court on all claims made in the Second Amended Complaint, the Court will address the facial Commerce Clause claim in resolving this case.

II FACTS

The following material facts are undisputed by the parties:

1. Plaintiff Walgreens, a corporation duly incorporated under the laws of Illinois with its principal place of business in Illinois, is a leading drugstore retailer in the United States and operates approximately 4000 drugstores in 43 states and in Puerto Rico. 10

2. Sales of prescription medicines represent approximately half of the sales in Walgreens’ drugstores, both nationally and in Puerto Rico. 11

3. Defendant John V. Rullan is the Secretary of Health of Puerto Rico and is the executive and administrative officer exercising full authority over the Health Department’s operations. Pursuant to 20 P.R. Laws Ann. § 383, the Secretary’s duties include the enforcement of all laws which relate to the establishment and supervision of pharmacies in Puerto Rico, 24 P.R. Laws Ann. §§ 334, et seq. (the “CNC Act”).

4. Puerto Rico’s CNC Act grew out of the U.S. government’s efforts to influence the regulation of the health care industries by the states.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Walgreen Company v. Rullan
405 F.3d 50 (First Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
292 F. Supp. 2d 298, 2003 U.S. Dist. LEXIS 19498, 2003 WL 22472158, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walgreen-co-v-rullan-prd-2003.